GRUPO TELEVISA, S.A.B.

6-K 1 tm2627404d1_6k.htm FORM 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October, 2026.

Commission File Number: 001-12610

GRUPO TELEVISA, S.A.B.

(Translation of registrant’s name into English)

Av. Vasco de Quiroga No. 2000, Colonia Santa Fe 01210 Mexico City, Mexico

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-Fx Form 40-F¨

GRUPO TELEVISA, S.A.B.

Av. Vasco de Quiroga No. 2000

Colonia Santa Fe

01210, Mexico City

www.televisair.com

BMV ticker symbol:

“TLEVISA”

Information Statement on Corporate Reorganization

filed pursuant to Article 35 of the Mexican General Provisions Applicable to Securities Issuers and Other Participants in the Securities Market

Capitalized terms not defined in this Information Statement shall have the meanings ascribed to them in the annual report of Grupo Televisa, S.A.B. (“Televisa” or the “Company”) for the year ended on December 31, 2025, filed with the National Banking and Securities Commission (the “CNBV”) and the Bolsa Mexicana de Valores, S.A.B. de C.V. (the “BMV” or the “Stock Exchange”), in accordance with the Mexican Securities Market Law and the Mexican General Provisions, which may be consulted atwww.televisair.com, on the Stock Exchange’s website atwww.bmv.com.mx or on the CNBV’s website atwww.gob.mx/cnbv, as well as in the “Glossary of Terms and Definitions” section of this Information Statement.

Brief Summary of the Corporate Reorganization. The corporate reorganization described in this Information Statement consists of the acquisition of 100% of the equity interests representing the capital stock of AT&T Comunicaciones Digitales, S. de R.L. de C.V. and Grupo AT&T Celullar, S. de R.L. de C.V. (together with their respective subsidiaries, “AT&T México”) by the buyer group (the “Purchaser’s Group”), comprised of: (i) Televisa, through CVQ, with a 50% economic interest; and (ii) Fintech Mercury S.à r.l. (“Fintech Mercury”), with the remaining 50% economic interest (the “Acquisition” or the “Corporate Reorganization”). The Acquisition will be carried out, directly and indirectly, through the investment and management trust identified by number F/6860 entered into by CVQ and Fintech Mercury, as trustors and beneficiaries, and Banco INVEX, S.A., Institución de Banca Múltiple, INVEX Grupo Financiero, as trustee. The relationship between the members of the Purchaser’s Group will be governed by a shareholders’ agreement (the “SHA”) to be entered into among them. The foregoing description is a summary, and shareholders should review the more detailed information included in this Information Statement, including the information contained in the section titled “Risk Factors”.

Characteristics of the Securities before and after the Corporate Reorganization:

If consummated, the Acquisition will not modify the characteristics of Televisa’s shares and CPOs.

Registration with the National Securities Registry does not imply certification as to the soundness of the securities, the solvency of the issuer, or the accuracy or truthfulness of the information contained in this Information Statement, nor does it validate any acts that may have been carried out in violation of law.

This Information Statement is not an offer by Televisa to purchase or sell securities.

For any questions regarding this Information Statement, please call 55 5261-2445, send an email torvillanuevab@televisa.com.mx, or contact us in writing at the address located at Avenida Vasco de Quiroga No. 2000, Colonia Santa Fe, 01210, Mexico City.

This Information Statement on Corporate Reorganization is available on Televisa’s website atwww.televisair.com, on the applicable BMV page atwww.bmv.com.mx and on the applicable CNBV page atwww.gob.mx/cnbv.

Mexico City, Mexico, October 13, 2026.

TABLE OF CONTENTS

Page